Cambridge, MA, September 9, 2020 — Chung Shan Medical University Hospital (CSMUH), one of the three key medical centers located in mid-Taiwan, has joined the TriNetX network to improve medical information processing and to better harness data held within its electronic medical records. The partnership will provide access to de-identified data of nearly 350,000 patient lives to the TriNetX network.
“Joining TriNetX provides us with the opportunity to dramatically improve the quality of our medical services, improve the flow of clinical information, and to help our doctors and hospital management better service our patients,” said Dr. Chih-Jen Tseng, Vice President and Information Architect at CSMUH. “We are looking forward to working with TriNetX to utilize our unified cloud platform to streamline research, accelerate data analysis, and simplify data acquisition.”
Due to its location, CSMUH attracts a large number of tourists coming from neighboring countries for medical treatment every year. Since its inception in the 1960s, CSMUH has developed distinctive, patient-centered, holistic care services, deploying the latest medical equipment with a modern intelligent medical center at its core. CSMUH began introducing electronic medical records more than 10 years ago, housing the data on a standardized information system structured with forward-thinking and big data use cases in mind.
“We evaluated several domestic and international enterprise companies with successful data integration platforms in medical network informatization and we found that TriNetX was best suited to help us reach our goals,” said Dr. Tseng. “Their ability to protect patient data, integrate data into the cloud, and provide easy-to-use analytics tools was particularly attractive to us. Joining the TriNetX network will help raise our standards to a level comparable to other major international medical centers and information libraries.”
TriNetX is the global health research network enabling healthcare organizations, pharmaceutical companies and contract research organizations (CROs) to collaborate, enhance trial design, improve site selection and planning, and bring new therapies to market faster. Each member of TriNetX shares in the consolidated value of its global, federated health research network that connects clinical researchers in real-time to the patient populations which they are attempting to study.
TriNetX offers the fastest growing collaborative research network representing over 170 healthcare organizations and health data partners, spanning 30 countries. TriNetX has presented over 7,800 clinical trial opportunities to its HCO members and has been cited in more than 200 publications.
“We are excited to continue to expand our global footprint into Taiwan with this new partnership with CSMUH,” said Steve Lethbridge, Senior Vice President of Global healthcare Partnerships at TriNetX. “We look forward to helping them reach their goal of bringing more clinical trial opportunities to its patient community and providing our network with a new research collaborator.”
CSMU consists of five colleges, College of Medicine, College of Oral Medicine, College of Medical Sciences and Technology, College of Health Care and Management, College of Medical Humanities and Social Sciences. There are 21 academic departments and 18 graduate institutes. We have 450 full-time faculty, 250 part-time faculty, and 260 staff members working on campus. Our total undergraduate and graduate enrolment is 7,566. As a medical university, we have four affiliated hospital districts — Da-Ching District, Chung-Kang District, Wen-Hsin District and Chung-Shing District. Each district has its own specialties and the state-of-the-art clinical facilities, including the first PET scanning machine in Taiwan. For more information please visit https://english.csmu.edu.tw/.
TriNetX is the global health research network that connects the world of drug discovery and development from pharmaceutical company to study site, and investigator to patient by sharing real-world data to make clinical and observational research easier and more efficient. TriNetX combines real time access to longitudinal clinical data with state-of-the-art analytics to optimize protocol design and feasibility, site selection, patient recruitment, and enable discoveries through the generation of real-world evidence. The TriNetX platform is HIPAA and GDPR compliant. For more information, visit TriNetX at www.trinetx.com or follow @TriNetX on Twitter.